S
Live / Registered — Registered and renewed (as of 17 Sept 2019)
What this means for you
Registered since 31 Oct 1989. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 31 Oct 2019).
Record
- Serial number
- 73769403
- Registration number
- 1562977
- Mark type
- Design + words
- Filed
- 14 Dec 1988
- Published for opposition
- 08 Aug 1989
- Registered
- 31 Oct 1989
- Next maintenance due
- 31 Oct 2019
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: PHARMACEUTICAL PREPARATION USEFUL IN THE MANAGEMENT OF GASTROINTESTINAL ENDOCRINE TUMORS
Owner
- Novartis AG, Basel, CH
- SANDOZ AG (SANDOZ LTD., SANDOZ S.A.), BASLE, CH
- SANDOZ PHARMACEUTICALS CORPORATION, E. HANOVER, NJ, US
- SANDOZ PHARMACEUTICALS CORPORATION, E. HANOVER, NJ, US
- SANDOZ PHARMACEUTICALS CORPORATION, E. HANOVER, NJ, US
Prosecution history
- 17 Sept 2019 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 17 Sept 2019 — REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
- 17 Sept 2019 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 16 Sept 2019 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 05 Aug 2019 — TEAS SECTION 8 & 9 RECEIVED
- 31 Oct 2018 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 19 Jun 2009 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 23 Feb 2009 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 23 Feb 2009 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 18 Feb 2009 — ASSIGNED TO PARALEGAL
- 16 Feb 2009 — TEAS SECTION 8 & 9 RECEIVED
- 01 Dec 2008 — CASE FILE IN TICRS
- 19 Dec 2004 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 06 Dec 2004 — PAPER RECEIVED
- 31 May 1996 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.